Latest Ratios: P/E Ratio 13.0x · EV/EBITDA 8.8x · ROE 14.4%. (2019–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $753M | $782M | $661M | $215M | $309M | $1.1B | — | — |
| Enterprise Value | $555M | $585M | $474M | $88M | $144M | $319M | — | — |
| P/E Ratio → | 13.03 | 13.55 | — | — | — | — | — | — |
| P/S Ratio | 1.61 | 1.67 | 1.78 | 1.03 | 2.58 | 12.01 | — | — |
| P/B Ratio | 1.73 | 1.79 | 1.81 | 0.56 | 0.52 | 1.27 | — | — |
| P/FCF | 82.76 | 85.98 | 14.01 | — | — | — | — | — |
| P/OCF | 81.86 | 85.05 | 13.92 | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.25 | 1.27 | 0.42 | 1.20 | 3.50 | — | — |
| EV / EBITDA | 8.77 | 9.24 | — | — | — | — | — | — |
| EV / EBIT | 8.77 | 9.24 | — | — | — | — | — | — |
| EV / FCF | — | 64.26 | 10.03 | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 50.9% | 50.9% | 20.0% | -39.8% | -49.6% | -16.1% | 32.2% | 100.0% |
| Operating Margin | 13.5% | 13.5% | -7.4% | -125.2% | -271.7% | -402.6% | -277.5% | -206.9% |
| Net Profit Margin | 12.3% | 12.3% | -10.9% | -130.2% | -278.5% | -407.2% | -274.2% | -239.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | 14.4% | 14.4% | -10.8% | -55.8% | -45.8% | -112.2% | — | -70.0% |
| ROA | 3.3% | 3.3% | -2.6% | -17.7% | -20.8% | -28.3% | -24.6% | -48.7% |
| ROIC | 22.8% | 22.8% | -9.4% | -57.5% | -94.9% | -319.9% | — | -56.4% |
| ROCE | 6.9% | 6.9% | -3.2% | -47.2% | -30.7% | -32.5% | -24.9% | -47.1% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.12 | 0.12 | 0.03 | 0.04 | 0.05 | — | — | — |
| Debt / EBITDA | 0.83 | 0.83 | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.45 | -0.51 | -0.33 | -0.28 | -0.90 | — | -0.20 |
| Net Debt / EBITDA | -3.12 | -3.12 | — | — | — | — | — | — |
| Debt / FCF | — | -21.73 | -3.97 | — | — | — | — | — |
| Interest Coverage | — | — | — | — | — | -0.85 | -4.51 | — |
Net cash position: cash ($250M) exceeds total debt ($52M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.35 | 0.35 | 1.36 | 1.31 | 1.61 | 6.30 | — | 1.28 |
| Quick Ratio | 0.35 | 0.35 | 1.36 | 1.31 | 1.61 | 6.30 | — | 1.28 |
| Cash Ratio | 0.19 | 0.19 | 0.74 | 0.46 | 0.70 | 4.30 | — | 1.28 |
| Asset Turnover | — | 0.25 | 0.24 | 0.14 | 0.08 | 0.06 | 0.05 | 0.20 |
| Inventory Turnover | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 7.7% | 7.4% | — | — | — | — | — | — |
| FCF Yield | 1.2% | 1.2% | 7.1% | — | — | — | — | — |
| Buyback Yield | 1.9% | 1.9% | 2.4% | 0.8% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 1.9% | 1.9% | 2.4% | 0.8% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $26M | $25M | $24M | $23M | $15M | $3M | $484488 |
Catastrophe-linked underwriting volatility
As reported in recent market data, Hippo's P/B ratio of 1.64 suggests that investors are pricing the company at a significant discount to its historical valuation peaks, likely reflecting skepticism regarding the long-term sustainability of its recent pivot toward positive net income and underwriting profitability.
The current P/B multiple appears to indicate that the market is still struggling to categorize Hippo as either a high-growth technology platform or a traditional, capital-intensive insurance carrier. Investors should monitor whether this valuation discount persists as the company demonstrates more consistent earnings, as a sustained improvement in ROE could justify a re-rating toward peer averages.
Based on the provided quarterly data, the combined ratio has exhibited extreme variance, ranging from 18.7% in 2025Q3 to 141.3% in 2025Q1, which underscores the inherent difficulty in maintaining consistent underwriting discipline within a portfolio heavily concentrated in catastrophe-exposed regions like Texas and California.
While the recent combined ratio of 94.1% in 2026Q1 suggests a return to underwriting profitability, the historical volatility warrants caution regarding the reliability of these margins. The fluctuation between loss ratios exceeding 100% and periods of relative stability implies that the company's risk-mitigation technology has yet to fully decouple its underwriting results from broader climate-driven loss cycles.
According to financial disclosures, Hippo's D/E ratio remains low at 0.11 as of 2026Q1, suggesting that the company is maintaining a conservative capital structure to support its insurance obligations while navigating the inherent volatility of its specialty underwriting business and reliance on reinsurance cessions.
The relatively low leverage appears to be a strategic necessity given the company's exposure to unpredictable, climate-driven loss events. Investors should monitor whether this capital-light approach remains viable if the reinsurance market hardens further, as any increase in retained risk would likely necessitate a more robust capital base to maintain regulatory solvency standards.
The most commonly misapplied metric for Hippo is the headline combined ratio, which, as shown in recent filings, often fails to account for the lumpy impact of reinsurance cessions and reserve development, thereby masking the underlying volatility of the company's core insurance underwriting performance.
Relying solely on the combined ratio can be misleading because it does not distinguish between organic underwriting success and the temporary benefits of favorable reinsurance treaties. Analysts should instead focus on the gross loss ratio and the stability of ceding commissions to better understand the true economic risk being retained by the company's balance sheet.
Includes 30+ ratios · 7 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying HIPO stock.
Hippo Holdings Inc.'s current P/E ratio is 13.0x. The historical average is 13.5x.
Hippo Holdings Inc.'s current EV/EBITDA is 8.8x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 9.2x.
Hippo Holdings Inc.'s return on equity (ROE) is 14.4%. The historical average is -46.7%.
Based on historical data, Hippo Holdings Inc. is trading at a P/E of 13.0x. Compare with industry peers and growth rates for a complete picture.
Hippo Holdings Inc. has 50.9% gross margin and 13.5% operating margin. Operating margin between 10-20% is typical for established companies.
Hippo Holdings Inc.'s Debt/EBITDA ratio is 0.8x, indicating low leverage. A ratio below 2x is generally considered financially healthy.